Newsroom | 2116 results

Sorted by: Latest

Food Tech
-

Veracity Launches Metabolic Power Protein: A Smarter Protein Designed to Strengthen Your Metabolism Without Toxicity 

NEW YORK--(BUSINESS WIRE)--Veracity Launches Metabolic Power Protein: A Smarter Protein Designed to Strengthen Your Metabolism Without Toxicity....
-

SymphonyAI Launches New Industrial AI Apps Purpose-Built for the CPG Food and Beverage Industry, Powered by Microsoft Azure

NEW YORK--(BUSINESS WIRE)--SymphonyAI, the global leader in Vertical AI product platforms, today announced eight new industrial AI applications purpose-built for the unique operational demands of CPG & Food and Beverage manufacturers, marking one of the most targeted expansions of IRIS Foundry to date. Unlike generic "manufacturing AI," these apps are engineered around high-speed lines, thermal variability, CIP/SIP complexity, micro-stoppages, drift conditions, and robotics. By combining Sy...
-

Five Guys Joins ezCater to Bring Its Iconic Burgers to Workplaces Nationwide

BOSTON--(BUSINESS WIRE)--ezCater, the #1 food tech platform for workplaces in the US, today announced that Five Guys is bringing approximately 800 of its locations onto the ezCater platform, which will give the fan-favorite burger brand access to high-value corporate catering orders from workplaces nationwide. This collaboration enables Five Guys to scale its national catering program and capture spend from organizations investing in food to boost productivity and office attendance. Based on a...
-

Papa Johns Partners with PAR Technology to Power POS and OPS Transformation Across 3,200 U.S. Restaurants

NEW HARTFORD, N.Y.--(BUSINESS WIRE)--Papa Johns today announced it has selected PAR POS™ and PAR OPS™ from PAR Technology Corporation (NYSE: PAR) to anchor its next-generation U.S. in-restaurant technology stack. The strategic partnership is a major milestone in Papa Johns multi-year effort to build a faster, more intelligent, and connected restaurant and digital ordering experience for guests, operators, and franchisees. “At Papa Johns, one of our strategic priorities is investing in and optim...
-

Samenvatting: Enginzyme en AGC creëren een schaalbaar proces voor een belangrijke bouwsteen van mRNA

STOCKHOLM--(BUSINESS WIRE)--Tijdens de mRNA Health-conferentie in Berlijn stelden enginzyme en AGC Inc. een schaalbaar proces voor om N1-methylpseudouridine-5'-trifosfaat (m¹ΨTP), een belangrijke bouwsteen voor mRNA-vaccins en -therapieën, te produceren. De snelle groei van op mRNA gebaseerde vaccins en therapieën heeft de vraag naar gemodifieerde nucleotiden zoals m¹ΨTP aanzienlijk doen stijgen, een bestanddeel dat mRNA-stabiliteit en -expressie bevordert en tegelijk de immunogeniciteit van mR...
-

Enginzyme et AGC créent un processus évolutif pour un ingrédient clé de l’ARNm

STOCKHOLM--(BUSINESS WIRE)--Lors de la conférence mRNA Health à Berlin, enginzyme et AGC Inc. ont présenté un processus évolutif visant à produire un ingrédient clé des vaccins et des thérapies à base d’ARNm, le N1-méthylpseudouridine-5’-triphosphate (m¹ΨTP). La croissance rapide des vaccins et des thérapies à base d’ARNm a entraîné une demande importante pour des nucléotides modifiés tels que le m¹ΨTP, qui améliore la stabilité et l’expression de l’ARNm tout en réduisant l’immunogénicité. Engi...
-

Resumen: Enginzyme y AGC crean un proceso escalable para un ingrediente clave del ARNm

ESTOCOLMO--(BUSINESS WIRE)--Durante la conferencia mRNA Health celebrada en Berlín, Enginzyme y AGC Inc. presentaron un proceso escalable para producir uno de los ingredientes clave para vacunas y terapias de ARNm, a saber, el N1-metilpseudouridina-5'-trifosfato (m¹ΨTP). La rápida proliferación de vacunas y terapias basadas en ARNm ha impulsado una demanda significativa de nucleótidos modificados como el m¹ΨTP, que mejora la estabilidad y la expresión del ARNm, además de reducir la inmunogenici...
-

Enginzyme und AGC entwickeln skalierbares Verfahren für wichtigen mRNA-Inhaltsstoff

STOCKHOLM--(BUSINESS WIRE)--Auf der mRNA-Health-Konferenz in Berlin stellten Enginzyme und AGC Inc. ein skalierbares Verfahren zur Herstellung eines wichtigen Inhaltsstoffs für mRNA-Impfstoffe und -Therapien vor: N1-Methylpseudouridin-5'-triphosphat (m¹ΨTP). Das rasante Wachstum von mRNA-basierten Impfstoffen und Therapeutika hat zu einer erheblichen Nachfrage nach modifizierten Nukleotiden wie m¹ΨTP geführt, die die Stabilität und Expression von mRNA verbessern und gleichzeitig die Immunogenit...
-

Riassunto: Enginzyme e AGC creano un processo scalabile per l'ingrediente chiave dell'mRNA

STOCCOLMA--(BUSINESS WIRE)--In occasione della conferenza mRNA Health a Berlino, enginzyme e AGC Inc. hanno presentato un processo scalabile per la produzione di un ingrediente chiave per vaccini e terapie a base di mRNA, l'N1-metilpseudouridina-5'-trifosfato (m¹ΨTP). La rapida crescita di vaccini e terapie a base di mRNA ha generato una notevole richiesta di nucleotidi modificati come m¹ΨTP, che migliora la stabilità e l'espressione dell'mRNA, riducendo al contempo l'immunogenicità. Enginzyme...
-

Cold Chain Tracking and Monitoring Market Report 2025: Profiles of 75+ Cold Chain Tracking Solution Providers, Insights from 30 Executive Interviews with Leading Companies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Cold Chain Tracking and Monitoring Market - 5th Edition" report has been added to ResearchAndMarkets.com's offering. The Cold Chain Tracking and Monitoring Market is the foremost source of information about the adoption of tracking solutions for refrigerated cargo and cargo containers, including trailers, intermodal containers, air freight ULDs and rail wagons. Whether you are a tracking solution provider, device vendor, cargo transportation stakeholder, teleco...